Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Profit After Tax (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Profit After Tax for 3 consecutive years, with -$36.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 25.99% to -$36.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$204.6 million, a 63.97% increase, with the full-year FY2025 number at -$204.6 million, up 63.97% from a year prior.
  • Profit After Tax was -$36.6 million for Q4 2025 at Nuvation Bio, up from -$55.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$13.8 million in Q4 2023 to a low of -$462.5 million in Q2 2024.
  • A 3-year average of -$70.7 million and a median of -$38.9 million in 2024 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: tumbled 2140.76% in 2024, then skyrocketed 87.24% in 2025.
  • Nuvation Bio's Profit After Tax stood at -$13.8 million in 2023, then plummeted by 258.63% to -$49.4 million in 2024, then grew by 25.99% to -$36.6 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Profit After Tax are -$36.6 million (Q4 2025), -$55.8 million (Q3 2025), and -$59.0 million (Q2 2025).